ArticleRevista da Sociedade Brasileira de Medicina Tropical2026
Prevalence of Latent Tuberculosis Infection in Vulnerable Groups in the State of Santa Catarina, Brazil.
Article in Revista da Sociedade Brasileira de Medicina Tropical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis remains a major public health challenge that exerts substantial pressure on healthcare systems worldwide. Despite advances in diagnosis and treatment, the proper management of latent tuberculosis infection (LTBI) remains inefficient, especially among vulnerable populations. In the State of Santa Catarina, Brazil, the absence of comprehensive and specific records on LTBI prevalence in these at-risk groups limits effective public health planning and interventions.
methodsInterferon-gamma release assay (IGRA) test records in the State of Santa Catarina, Brazil, contained partial information on risk factors for LTBI. Multiple imputations were used to estimate the likely risk groups among individuals without such information. The study was approved by the Human Research Ethics Committee under protocol number CAAE 79499224.4.0000.5361.
resultsThe estimated LTBI prevalence among individuals with available IGRA results was 6.89%, with higher rates among people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (18.25%) and immigrants (3.65%). Underreporting was notable among individuals deprived of liberty, those experiencing homelessness, those who use illicit drugs, and those with diabetes mellitus. Missing data were frequent among individuals living with HIV; people of African, Indigenous, or Asian descent; and those exposed to drug-resistant TB. More than 10% of LTBI cases occurred in children and adolescents aged <15 years.
conclusionHIV was the most prevalent risk factor among IGRA-positive individuals and was substantially underestimated. An urgent expansion of LTBI identification efforts is needed for all vulnerable populations, with special attention paid to children and adolescents who present a high risk of progressing to active TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.